mesothelioma
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2022/02/shutterstock_402400207.jpg)
Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.
Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.